Conventional dose CRRT

PreclinicalSmall molecule

Conventional dose CRRT is one of 49 small molecule programs targeting Acute Kidney Injury. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Acute Kidney InjuryActive, not recruiting

Neuromuscular BlockadeCompleted

Acute Kidney InjuryPreclinical

Active, not recruiting

Neuromuscular BlockadePreclinical

Completed

Competition

Competitive Landscape

90 competitors in Acute Kidney Injury

#DrugCompanyPhaseTrials

Levophed

GGeneral Hospital of Ningxia Medical University

Approved

3 2

Glypressin

MMallinckrodt

Approved

2 3

Acetadote

AArbor Pharmaceuticals, Inc.

Approved

—4

Vidaza

KKaruna Therapeutics, Inc., a Bristol Myers Squibb company

Approved

—5

Giapreza

LLa Jolla Pharmaceutical Company

Phase 3

2 6

Oraverse

LLife Extension Foundation Inc.

Phase 3

1 7

Northera

Lundbeck

Phase 2

1 8

Lamisil

Novartis

Phase 2

1 9

Pitressin

AAultman Health Foundation

Phase 2

1 10

Arginine Vasopressin

SStanford University

Phase 3

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Polycystic Ovary Syndrome1 trial

GnRH Antagonist Versus GnRH Agonist in Polycystic Ovary Syndrome During in Vitro Fertilization - Embryo Transfer

Completed·SSeoul National University Hospital·Phase 3·NCT01402336·43 enrolled

Croup1 trial

The Effect and Safety of Low Dose Nebulized Epinephrine in Croup

Unknown status·SSeoul National University Hospital·Phase 4·NCT01664507·84 enrolled

Contrast Agent1 trial

Low Contrast Agent and Radiation Dose Protocol for Liver CT in Patients With HCC

Completed·SSeoul National University Hospital·N/A·NCT04722120·68 enrolled

Neuromuscular Blockade1 trial

Effects of Neuromuscular Blockade Level and Intra-abdominal Pressure on Surgical Conditions and Cardiopulmonary Responses During Laparoscopic Colon Surgery With the Trendelenburg Position

Completed·SSeoul National University Hospital·N/A·NCT02249585·131 enrolled

Acute Kidney Injury1 trial

Effects of HIgh Volume COntinuous REnal Replacement Therapy in Patients With Septic Acute Kidney Injury

Completed·SSeoul National University Hospital·N/A·NCT01191905·212 enrolled

Sources

References

[1]
ClinicalTrials.gov — 5 trial records for Conventional dose CRRT. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Conventional dose CRRT compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Conventional dose CRRT. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Seoul National University Hospital company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: SSeoul National University Hospital

Conventional dose CRRT

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Polycystic Ovary Syndrome1 trial

Croup1 trial

Contrast Agent1 trial

Neuromuscular Blockade1 trial

Acute Kidney Injury1 trial

References

Drug Info

Quick Facts

Related News